Impact of Body Mass Index on Platelet Aggregation After Administration of a High Loading Dose of 600 mg of Clopidogrel Before Percutaneous Coronary Intervention

Abciximab in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention After Clopidogrel Pretreatment<SUBTITLE>The ISAR-REACT 2 Randomized Trial</SUBTITLE>

Adnan Kastrati · JAMA · 2006 · 756 citations

Medicine, Cardiology, Pharmacology +17

The impact of obesity on the short-term andlong-term outcomes after percutaneous coronary intervention: the obesity paradox?

Luis Gruberg, Neil J. Weissman, Ron Waksman et al. · Journal of the American College of Cardiology · 2002 · 697 citations

Medicine, Cardiology, Surgery +15

Absorption, Metabolization, and Antiplatelet Effects of 300-, 600-, and 900-mg Loading Doses of Clopidogrel

Nicolas von Beckerath, Dirk Taubert, Gisela Pogátsa-Murray et al. · Circulation · 2005 · 627 citations · Full text

Medicine, Cardiology, Pharmacology +17

Impact of the Degree of Peri-Interventional Platelet Inhibition After Loading With Clopidogrel on Early Clinical Outcome of Elective Coronary Stent Placement

Willibald Hochholzer, Dietmar Trenk, Hans-Peter Bestehorn et al. · Journal of the American College of Cardiology · 2006 · 586 citations

Medicine, Cardiology, Pharmacology +16

A Clinical Trial of Abciximab in Elective Percutaneous Coronary Intervention after Pretreatment with Clopidogrel

Adnan Kastrati, Julinda Mehilli, Helmut Schühlen et al. · New England Journal of Medicine · 2004 · 569 citations · Full text

Medicine, Cardiology, Pharmacotherapy +17